日本核医学会学術総会/日本核医学技術学会総会学術大会

[JSL1]Faced with life - From the scene of Churaumi

Keiichi Ueda(Zoological Laboratory, Okinawa Churashima Research Center, Okinawa, Japan)

[JSL2]Visualize neural circuits of imagination and intelligence

Kenji Doya(Neural Computation Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan)

[IL1]Driving Value of Nuclear Medicine and Molecular Imaging: SNMMI Value Initiative

Satoshi Minoshima(University of Utah, USA)

[IL2]Molecular Imaging in the Age of Theranostics

Steven M. Larson(Memorial Sloan Kettering Cancer Center, New York, New York, USA)

[IL3]Use of Molecular PET imaging in Alzheimer's Disease Prevention Trials

Reisa Sperling¹(1.Brigham & Women's Hospital, Boston, MA, USA, 2.Massachusetts General Hospital, Boston, MA, USA)

[IL4]PET imaging biomarker quantification and standardization

Ronald Boellaard(Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands)

[IL5]Recent development of whole body PET

Terry Jones(Department of Radiology, University of California, Davis, CA,USA)

[IL6]Diagnostic and therapeutic perspectives of radiolabelled nanobodies

Kristoff Muylle(Department of Nuclear Medicine, University Hospital Brussels (UZ Brussel), Brussels, Belgium)

[JS1]The problems and measures of the pediatric examinations in JSNM pediatric dosage card.

Keiichi Sugibayashi(Department of Radiorogy, Kansai Medical University Hoapital, Osaka Japan)

[JS2]Suggested changes of Japanese consensus guidelines for pediatric nuclear medicine

Mayuki Uchiyama(Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan)

[JS3]Dose reduction in pediatric nuclear medicine and SPECT/CT "Let's pick up slight uptake"

Masayuki Kitamura(Department of Radiology, National Center for Child Health and Development)

[JS4]Practice, technology and ingenuity of pediatric nuclear medicine examination

Katsunori Fujita(National Center for child Health and Development)

[PETFS-01]1.Overview of JSNM PET Imaging Site Qualification Program (J-PEQi)

Yuichi Kimura(KINDAI UNIVERSITY)

[PETFS-02]2. JSNM PET Imaging Site Qualification Program (J-PEQi) as seen from the auditor

Keisuke Tsuda (Tsukuba International University)

[PETFS-03]3. JSNM PET Imaging Site Qualification Program (J-PEQi) : Experience of the audit

Akihiro Nakamura (Hamamatsu Medical Photonics Foundation, Hamamatsu Medical Imaging Center )

[PETFS-04]4. Practical implementation of the phantom study for JSNM PET Imaging Site Qualification Program (J-PEQi)

Yasuhiko Ikari^1,2(1.Kobe City Medical Center General Hospital, 2.Cmic Co., Ltd.)

[JSP]Techniques for English presentation to enhance international transmission skills ～From speech to question and answer～

Toyoko Shimamura(Eglobe Inc.)

[LS1-1]Clinical utility of GI-BONE in prostate cancer

Shinichi Sakamoto(Department of Urology, Chiba University Hospital)

[LS1-2]Assessing therapeutic efficacy for prostate cancer induced bone metastases through bone SPECT/CT and GI-BONE

Yoshimitsu Fukushima(Department of Radiology, Nippon Medical School)

[LS2-1]Technologies Adopted on United Imaging Digital PET-CT ClariTom uMI780

Xiong Dian(Shanghai United Imaging Healthcare Co., Ltd)

[LS2-2]Digital PET-CT advanced value for the diagnosis and theranostic

Wang Feng(China Nanjing First Hospital)

[LS3-1]Current status and issues of Ra-223 dichloride therapy

Koichiro Abe(Professor, Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women's Medical University)

[LS3-2]Clinical Experience of Ra-223 and a path forward

Hiroji Uemura(Department of Urology and Renal Transplantation, Yokohama City University Medical Center)

[LS4-1]Let's study cutting edge advancements of biomarkers techniques for Alzheimer's disease

Hitoshi Shimada(Department of Functional Brain Imaging Research (DOFI), National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan)

[LS5-1]Factors affecting data variability and sample size in CNS PET studies

Gregory Klein(F. Hoffmann-La Roche Ltd. Basel, Switzerland)

[LS6-1]Perspectives of Fully Digital Si-PM Technology for Expanding PET/CT Capabilities to New Clinical Practice

Keiichi Magota(Division of Medical Imaging and Technology, Hokkaido University Hospital)

[LS6-2]Advances in PET technology and quantification: Recent topics by Standardization and Harmonization

Ronald Boellaard(Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands)

[LS7-1]Standardization on bone SPECT images

Kenta Miwa(School of Health Science, International University of Health and Welfare)

[LS7-2]Current status of bone scintigraphy and its future prospects

Tadaki Nakahara(Department of Radiology, Keio University School of Medicine)

[LS8-1]Feasibility of breast cancer screening by Elmammo dedicated breast PET system

Yoko Satoh(Yamanashi PET imaging clinic)

[LS9-1]First experiences with the digital Biograph Vision PET/CT system

Ronald Boellaard(Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands)

[LS10-1]Online registry for the prevention of dementia in Japan

Hiroshi Matsuda(Integrative Brain Imaging Center, National Center of Neurology and Psychiatry)

[LS11-1]1. Initial experience of Discovery MI.v and Data-driven respiratory gating

Kentaro Takanami(Department of Diagnostic Radiology, Tohoku University Hospital)

[LS11-2]2. Bone Imaging with SwiftScan

Kenichi Nakajima(Department of Nuclear Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University.)

[LS12-1]Usefulness of the quantification method for cerebral blood flow without blood sampling (Improved Brain Uptake Ratio (IBUR) method)

Shigeki ITO(Department of Medical imaging, Graduate school of life sciences, Kumamoto university)

[LS12-2]Fine performance of triple-detector gamma camera GCA-9300R in SPECT imaging and dynamic analysis

Sunao Mizumura(Department of Radiology, Toho University, Medical Center Omori)

[WIP-1]Latest Nuclear Medicine Technology from Canon

Nobutoku Motomura(Canon Medical Systems Corporation)

[WIP-2]2．a dedicated breast PET scanner “Elmammo Avant Class” Up-to-date

Yoshiyuki Yamakawa(Research & Development Department, Medical Systems Division, Shimadzu Corporation)

[WIP-3]3．Philips innovative solution for Molecular Imaging

Ko Higuchi(D&T Business Marketing Group AMI)

[WIP-4]4．The latest topic of Siemens Molecular Imaging

Tetsuro Odagawa(Molecular Imaging Dpt., Siemens Healthcare K.K.)

[WIP-5]5．Introduction of 800 Series that new family of five nuclear medicine systems

Kumiko Ohkubo(MI Sales & Promotion, GE Helthcare Japan Corp.)

[NMEL1]Reduced cardiac MIBG uptake is a potential biomarker for the presence of Lewy bodies

Satoshi Orimo(Department of Neurology, Kanto Central Hospital, Tokyo, Japan)

[NMEL2]PET/MRI

Hidehiko Okazawa(Biomedical Imaging Research Center, University of Fukui, Fukui, Japan)

[NMEL3]Nuclear imaging diagnosis and artificial intelligence: its utilization as a second opinion

Kenichi Nakajima(Department of Nuclear Medicine, Kanazawa University, Kanazawa, Japan)

[NMEL4]Radionuclide therapy (Targeted Radioisotope Therapy)

Tatsuya Higashi(Dept. of Molecular Imaging and Theranostics, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST))

[NMEL5]About the medical radiation management in the medical policy

Takeshi Sasaki(Medical Care Planning Division,Health Policy Bureau,Ministry of Health,Labor and Welfare,Tokyo,Japan)

[NMEL6]Confkict of interest(COI) and Reliability

Kaoru Hosoi(Department of Clinical Research Sci.,Fukuoka University Graduate School of Medicine, Fukuoka,Japan)

[JEJS1]Opening Remarks

[JEJS2]Keynote Lecture
Artificial Intelligence in Molecular Brain Imaging

Satoshi Minoshima(University of Utah, USA)

[JEJS3]1．Nuclear Imaging for the diagnosis of dementia with Lewy body: a neurologist's perspective

Pai-Yi Chiu(Department of Neurology, Show-Chwan Memorial Hospital)